
AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Amcor, you need to believe the Berry integration, cost synergies, and portfolio pruning can offset soft volumes and a leveraged balance sheet. The latest quarter’s modest EPS beat, despite weaker revenue, supports the near term earnings resilience catalyst but does not meaningfully change the key risk around execution on divestitures and debt reduction.
The most relevant development here is Amcor’s upcoming presentation at the 2026 World Chemical Forum, which keeps management in front of key customers and suppliers. For investors, that visibility ties directly into the earnings and synergy story, as it highlights how Amcor positions its resin sourcing, innovation, and integration efforts while the market is increasingly focused on whether cost savings and portfolio changes can support margins.
Yet behind Amcor’s recent earnings resilience, investors should be aware of the unresolved risk around asset sales and leverage, especially if...
Read the full narrative on Amcor (it's free!)
Amcor's narrative projects $24.0 billion revenue and $1.7 billion earnings by 2029.
Uncover how Amcor's forecasts yield a $52.54 fair value, a 32% upside to its current price.
While consensus focuses on measured synergy delivery, the most optimistic analysts once projected revenue of about US$25.8 billion and earnings of roughly US$2.3 billion by 2028, so Amcor’s latest EPS beat could either reinforce that upbeat view or prompt a rethink of how realistic those assumptions really are, depending on how you weigh integration execution against the very real risk that volumes stay weak for longer.
Explore 8 other fair value estimates on Amcor - why the stock might be worth as much as 78% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com